Data / Drug companies / Cipla Ltd.
Cipla Ltd.: 107 products in the FDA NDC directory, labeler code 53104
Cipla Ltd. (labeler code 53104) lists 107 products in the FDA National Drug Code Directory. By type: 107 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on November 5, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 53104
- Products in commercial distribution
- 107
- Packages
- 107
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 10
- Earliest marketing start
- June 17, 1999
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 107 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 107 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 107 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Acalabrutinib maleate | 53104-7752 | Powder | Bulk ingredients | November 5, 2026 |
| Letrozole | 53104-7751 | Powder | Bulk ingredients | October 26, 2026 |
| Nilotinib d-tartrate | 53104-7750 | Powder | Bulk ingredients | October 26, 2026 |
| Bictegravir sodium | 53104-7749 | Powder | Bulk ingredients | September 30, 2026 |
| Dolutegravir sodium | 53104-7748 | Powder | Bulk ingredients | September 28, 2026 |
| Fluconazole | 53104-7569 | Powder | Bulk ingredients | September 10, 2026 |
| Felodipine | 53104-7519 | Powder | Bulk ingredients | September 10, 2026 |
| Lamotrigine | 53104-7606 | Powder | Bulk ingredients | August 26, 2026 |
| Lenacapavir sodium | 53104-7747 | Powder | Bulk ingredients | July 9, 2026 |
| Sorafenib tosylate | 53104-7673 | Powder | Bulk ingredients | June 29, 2026 |
| Edaravone | 53104-7744 | Powder | Bulk ingredients | October 28, 2024 |
| Rilpivirine | 53104-7743 | Powder | Bulk ingredients | June 12, 2024 |
| Tenofovir alafenamide fumarate | 53104-7742 | Powder | Bulk ingredients | April 30, 2024 |
| Empagliflozin | 53104-7723 | Powder | Bulk ingredients | April 30, 2024 |
| Cabotegravir sodium | 53104-7741 | Powder | Bulk ingredients | November 16, 2023 |
| Cabotegravir | 53104-7740 | Powder | Bulk ingredients | November 16, 2023 |
| Acalabrutinib | 53104-7746 | Powder | Bulk ingredients | May 4, 2021 |
| Rivaroxaban | 53104-7730 | Powder | Bulk ingredients | April 15, 2021 |
| Enzalutamide | 53104-7745 | Powder | Bulk ingredients | March 20, 2021 |
| Lenalidomide | 53104-7726 | Powder | Bulk ingredients | February 4, 2021 |
| Dasatinib | 53104-7725 | Powder | Bulk ingredients | March 11, 2020 |
| Cinacalcet hydrochloride | 53104-7699 | Powder | Bulk ingredients | November 14, 2019 |
| Leflunomide | 53104-7557 | Powder | Bulk ingredients | August 28, 2019 |
| Pazopanib hydrochloride | 53104-7727 | Powder | Bulk ingredients | February 4, 2019 |
| Levalbuterol hydrochloride | 53104-7719 | Powder | Bulk ingredients | December 7, 2018 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.